_id
69147932ccc777a4e85d8f29
Ticker
MIRA
Name
MIRA Pharmaceuticals, Inc. Common Stock
Exchange
NASDAQ
Address
1200 Brickell Avenue, Miami, FL, United States, 32183
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://mirapharmaceuticals.com
Description
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Last Close
1.48
Volume
121494
Current Price
1.48
Change
-0.02
Last Updated
2026-01-05T10:31:11.010Z
Image
data:image/webp;base64,UklGRvgAAABXRUJQVlA4IOwAAACwBgCdASpAAEAAPrVWpE4nJKOiKBQIqOAWiWkADOlDQTpw6SgTx/YkxMNq+YhMUlrrhLhoNEsCrQCB4UkgAAD++E0a+o/5py0D+GEkX2FCFNo0AKhSPwjELZQrNI1jQkJvNpi4zQi3W7/kLWHO7VJt5D9nuJmoEe9Q3E5z39R+rEwXXwIzx9QqxyxX85XUaUt50D2Q5/h6Us+54+nr3rN0emHIIWMVg+v+VoD4Nlpmx5IuaomHjd72Ufb51o6/emRGLjbPjQyD8IQcuwI2i4jGDXkLRdL7NTS9gYls+FaGF7Vz3MfZqbmhBgAAAA==
Ipo Date
2023-08-03T00:00:00.000Z
Market Cap
62395372
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
17.75
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1316985
Operating Income
-1316985
Interest Expense
-
Pretax Income
-1137673
Net Income
-22694494
Eps
-1.1774088924861894
Dividends Per Share
-
Shares Outstanding
41876087
Income Tax Expense
-
EBITDA
-1137673
Operating Margin
-
Total Other Income Expense Net
179312
Cash
2641539
Short Term Investments
4894366
Receivables
35439
Inventories
-
Total Current Assets
7597841
Property Plant Equipment
-
Total Assets
7633280
Payables
83926
Short Term Debt
-
Long Term Debt
-
Total Liabilities
83926
Equity
7549354
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-174065
Cash From Operations
-1096954
Capital Expenditures
4
Cash From Investing
-
Cash From Financing
3008018
Net Change In Cash
1911064
Cf_currency_symbol
USD
PE
-
PB
3.7787235252181843
ROE
-300.6150460026116
ROA
-297.3098589335122
FCF
-1096958
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1316985
Quarters > 0 > income Statement > operating Income
-1316985
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1137673
Quarters > 0 > income Statement > net Income
-22694494
Quarters > 0 > income Statement > eps
-1.1774088924861894
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19274947
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1137673
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
179312
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2641539
Quarters > 0 > balance Sheet > short Term Investments
4894366
Quarters > 0 > balance Sheet > receivables
35439
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7597841
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
7633280
Quarters > 0 > balance Sheet > payables
83926
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
83926
Quarters > 0 > balance Sheet > equity
7549354
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-22694494
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-174065
Quarters > 0 > cash Flow > cash From Operations
-1096954
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
3008018
Quarters > 0 > cash Flow > net Change In Cash
1911064
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.1774088924861894
Quarters > 0 > ratios > PB
3.7787235252181843
Quarters > 0 > ratios > ROE
-300.6150460026116
Quarters > 0 > ratios > ROA
-297.3098589335122
Quarters > 0 > ratios > FCF
-1096958
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1546100
Quarters > 1 > income Statement > operating Income
-1546100
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1537712
Quarters > 1 > income Statement > net Income
-1537712
Quarters > 1 > income Statement > eps
-0.09052559893487105
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16986488
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1546100
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
8388
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
730475
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
35439
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
832879
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
868318
Quarters > 1 > balance Sheet > payables
298459
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
298459
Quarters > 1 > balance Sheet > equity
569859
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1537712
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
248495
Quarters > 1 > cash Flow > cash From Operations
-799651
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
323841
Quarters > 1 > cash Flow > net Change In Cash
-475810
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.09052559893487105
Quarters > 1 > ratios > PB
44.11618003751805
Quarters > 1 > ratios > ROE
-269.84078517668405
Quarters > 1 > ratios > ROA
-177.09088145126555
Quarters > 1 > ratios > FCF
-799651
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
11161056
Quarters > 2 > income Statement > cost Of Revenue
5580528
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1805200
Quarters > 2 > income Statement > operating Income
-1805200
Quarters > 2 > income Statement > interest Expense
115253
Quarters > 2 > income Statement > pretax Income
-1783779
Quarters > 2 > income Statement > net Income
-1783779
Quarters > 2 > income Statement > eps
-0.10716528971646283
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16645119
Quarters > 2 > income Statement > income Tax Expense
1768187
Quarters > 2 > income Statement > EBITDA
-1805200
Quarters > 2 > income Statement > operating Margin
-16.174096787974186
Quarters > 2 > income Statement > total Other Income Expense Net
21421
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1206285
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1364899
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1400338
Quarters > 2 > balance Sheet > payables
100673
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
106173
Quarters > 2 > balance Sheet > equity
1294165
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1783779
Quarters > 2 > cash Flow > depreciation
-38105
Quarters > 2 > cash Flow > change In Working Capital
-721060
Quarters > 2 > cash Flow > cash From Operations
-1630027
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3381
Quarters > 2 > cash Flow > net Change In Cash
-1626646
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.10716528971646283
Quarters > 2 > ratios > PB
19.035266847735798
Quarters > 2 > ratios > ROE
-137.83242476809372
Quarters > 2 > ratios > ROA
-127.38203205226166
Quarters > 2 > ratios > FCF
-1630030
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.14604621641536428
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2437801
Quarters > 3 > income Statement > operating Income
-2437801
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2399696
Quarters > 3 > income Statement > net Income
-2399696
Quarters > 3 > income Statement > eps
-0.1572742801955062
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
15258032
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2437801
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-2399696
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2832931
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2887660
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
2923099
Quarters > 3 > balance Sheet > payables
723349
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
723349
Quarters > 3 > balance Sheet > equity
2199750
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2399696
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
47885
Quarters > 3 > cash Flow > cash From Operations
-1805030
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
493401
Quarters > 3 > cash Flow > net Change In Cash
-1311629
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.1572742801955062
Quarters > 3 > ratios > PB
10.265660806909876
Quarters > 3 > ratios > ROE
-109.08948744175476
Quarters > 3 > ratios > ROA
-82.09424313032162
Quarters > 3 > ratios > FCF
-1805030
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
8018328
Annuals > 0 > income Statement > operating Income
-8018328
Annuals > 0 > income Statement > interest Expense
165669
Annuals > 0 > income Statement > pretax Income
-7852659
Annuals > 0 > income Statement > net Income
-7852659
Annuals > 0 > income Statement > eps
-0.5084552732559107
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
15444149
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-8018330
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
165669
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2832931
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2887660
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
2923099
Annuals > 0 > balance Sheet > payables
723349
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
723349
Annuals > 0 > balance Sheet > equity
2199750
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7852659
Annuals > 0 > cash Flow > depreciation
-2
Annuals > 0 > cash Flow > change In Working Capital
371248
Annuals > 0 > cash Flow > cash From Operations
-5560606
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3790971
Annuals > 0 > cash Flow > net Change In Cash
-1769635
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.5084552732559107
Annuals > 0 > ratios > PB
10.46108967382657
Annuals > 0 > ratios > ROE
-356.9796113194681
Annuals > 0 > ratios > ROA
-268.641568417628
Annuals > 0 > ratios > FCF
-5560610
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
8526049
Annuals > 1 > income Statement > gross Profit
-8526049
Annuals > 1 > income Statement > operating Expenses
8526049
Annuals > 1 > income Statement > operating Income
-8526049
Annuals > 1 > income Statement > interest Expense
3456294
Annuals > 1 > income Statement > pretax Income
-11982343
Annuals > 1 > income Statement > net Income
-11982343
Annuals > 1 > income Statement > eps
-0.6453862452317813
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
18566158
Annuals > 1 > income Statement > income Tax Expense
-8526.05
Annuals > 1 > income Statement > EBITDA
-8526049
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-3456294
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4602566
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
11862
Annuals > 1 > balance Sheet > inventories
-11862
Annuals > 1 > balance Sheet > total Current Assets
4858230
Annuals > 1 > balance Sheet > property Plant Equipment
5061
Annuals > 1 > balance Sheet > total Assets
4932443
Annuals > 1 > balance Sheet > payables
538564
Annuals > 1 > balance Sheet > short Term Debt
5061
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
558097
Annuals > 1 > balance Sheet > equity
4374346
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-11982343
Annuals > 1 > cash Flow > depreciation
732292
Annuals > 1 > cash Flow > change In Working Capital
-639688
Annuals > 1 > cash Flow > cash From Operations
-4532403
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
8783991
Annuals > 1 > cash Flow > net Change In Cash
4251588
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6453862452317813
Annuals > 1 > ratios > PB
6.324048308021359
Annuals > 1 > ratios > ROE
-273.9230733005574
Annuals > 1 > ratios > ROA
-242.92917323119596
Annuals > 1 > ratios > FCF
-4532404
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
7047940
Annuals > 2 > income Statement > operating Income
-7047940
Annuals > 2 > income Statement > interest Expense
10250
Annuals > 2 > income Statement > pretax Income
-7058190
Annuals > 2 > income Statement > net Income
-7058190
Annuals > 2 > income Statement > eps
-0.4786781027278763
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
14745170
Annuals > 2 > income Statement > income Tax Expense
-7047.94
Annuals > 2 > income Statement > EBITDA
-7047940
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-10250
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
350978
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
494405
Annuals > 2 > balance Sheet > property Plant Equipment
363669
Annuals > 2 > balance Sheet > total Assets
858074
Annuals > 2 > balance Sheet > payables
905554
Annuals > 2 > balance Sheet > short Term Debt
406964
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1454306
Annuals > 2 > balance Sheet > equity
-596232
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-7058190
Annuals > 2 > cash Flow > depreciation
7047.94
Annuals > 2 > cash Flow > change In Working Capital
146581
Annuals > 2 > cash Flow > cash From Operations
-5604759
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
3146185
Annuals > 2 > cash Flow > net Change In Cash
-2458574
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.4786781027278763
Annuals > 2 > ratios > PB
-36.84858125696038
Annuals > 2 > ratios > ROE
1183.79925934871
Annuals > 2 > ratios > ROA
-822.561923563702
Annuals > 2 > ratios > FCF
-5604759
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
2152162
Annuals > 3 > income Statement > operating Income
-2152162
Annuals > 3 > income Statement > interest Expense
24374
Annuals > 3 > income Statement > pretax Income
-2176536
Annuals > 3 > income Statement > net Income
-2176536
Annuals > 3 > income Statement > eps
-0.1476100987645446
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
14745170
Annuals > 3 > income Statement > income Tax Expense
-2152.16
Annuals > 3 > income Statement > EBITDA
-2152162
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-24374
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2809552
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2909552
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
3355164
Annuals > 3 > balance Sheet > payables
228406
Annuals > 3 > balance Sheet > short Term Debt
293062
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1093806
Annuals > 3 > balance Sheet > equity
2261358
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2176536
Annuals > 3 > cash Flow > depreciation
2152.16
Annuals > 3 > cash Flow > change In Working Capital
776006
Annuals > 3 > cash Flow > cash From Operations
-1376156
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
4182217
Annuals > 3 > cash Flow > net Change In Cash
2806061
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.1476100987645446
Annuals > 3 > ratios > PB
9.715535222640556
Annuals > 3 > ratios > ROE
-96.24906803787813
Annuals > 3 > ratios > ROA
-64.87122537080154
Annuals > 3 > ratios > FCF
-1376156
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.1774088924861894
Valuation > metrics > PB
3.7787235252181843
Valuation > final Score
42.212764747818156
Valuation > verdict
26.0% Overvalued
Profitability > metrics > ROE
-300.6150460026116
Profitability > metrics > ROA
-298.69661657831483
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.011116977691071315
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
90.53024092653051
Liquidity > metrics > Quick Ratio
90.53024092653051
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-689
Prev Risks > 1
-3
Prev Risks > 2
-196
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:12:34.907Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-03
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0682
Earnings History > 0 > eps Estimate
-0.09
Earnings History > 0 > eps Difference
0.0218
Earnings History > 0 > surprise Percent
24.2222
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-03
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.09
Earnings History > 1 > eps Estimate
-0.1
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
10
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-28
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.11
Earnings History > 2 > eps Estimate
-0.16
Earnings History > 2 > eps Difference
0.05
Earnings History > 2 > surprise Percent
31.25
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.175
Earnings History > 3 > eps Estimate
-0.13
Earnings History > 3 > eps Difference
-0.045
Earnings History > 3 > surprise Percent
-34.6154
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.14
Earnings History > 4 > eps Estimate
-0.11
Earnings History > 4 > eps Difference
-0.03
Earnings History > 4 > surprise Percent
-27.2727
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.11
Earnings History > 5 > eps Estimate
-0.12
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
8.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.12
Earnings History > 6 > eps Estimate
-0.1
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-20
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.37
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
-0.14
Earnings History > 7 > surprise Percent
-60.8696
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.26
Earnings History > 8 > eps Estimate
-0.08
Earnings History > 8 > eps Difference
-0.18
Earnings History > 8 > surprise Percent
-225
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.1
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.1
Earnings History > 9 > surprise Percent
-
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan MIRA Pharmaceuticals Inc. stock deliver consistent earnings growth - Global Markets & Safe Entry Zone Identification bollywoodhelpline.com
Read more →Will AOMN stock deliver shareholder value - Watch List & Reliable Entry Point Trade Alerts bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$17.75
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of MIRA Pharmaceuticals, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0682
EPS Estimate
-0.09
EPS Difference
0.0218
Surprise Percent
24.2222%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.